Difference between revisions of "Bacillus Calmette-Guérin (BCG, TheraCys)"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
Line 1: Line 1:
  
 
==General information==
 
==General information==
Class/mechanism: Live mycobacteria which promote a local acute inflammatory and sub-acute granulomatous reaction with macrophage and leukocyte infiltration in the urothelium and lamina propria of the urinary bladder.  This results in a likely T-lymphocyte dependent anti-tumor effect.<ref name="insert">[https://www.vaccineshoppecanada.com/secure/pdfs/ca/immucyst_e.pdf Bacillus Calmette-Guerin (BCG) package insert]</ref><ref>[http://hemonc.org/docs/chemotherapypackageinsert/bacilluscalmetteguerin.pdf Bacillus Calmette-Guerin (BCG) package insert (locally hosted backup)]</ref>
+
Class/mechanism: Live mycobacteria which promote a local acute inflammatory and sub-acute granulomatous reaction with macrophage and leukocyte infiltration in the urothelium and lamina propria of the urinary bladder.  This results in a likely T-lymphocyte dependent anti-tumor effect.<ref name="insert">[https://www.vaccineshoppecanada.com/secure/pdfs/ca/immucyst_e.pdf Bacillus Calmette-Guerin (BCG) package insert]</ref><ref>[http://hemonc.org/docs/packageinsert/bacilluscalmetteguerin.pdf Bacillus Calmette-Guerin (BCG) package insert (locally hosted backup)]</ref>
 
<br>Route: Intravesicular
 
<br>Route: Intravesicular
 
<br>Extravasation: n/a
 
<br>Extravasation: n/a

Revision as of 16:30, 29 November 2011

General information

Class/mechanism: Live mycobacteria which promote a local acute inflammatory and sub-acute granulomatous reaction with macrophage and leukocyte infiltration in the urothelium and lamina propria of the urinary bladder. This results in a likely T-lymphocyte dependent anti-tumor effect.[1][2]
Route: Intravesicular
Extravasation: n/a

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the package insert[1].

Patient drug information

Regimens

Standard format will be:
<acronym (if any)> <generic drug1, generic drug2, generic drug3, etc.> (disease)

References